Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up
BioSpace
Sun, 11/5/23 - 11:12 pm
Tags:
Novo Nordisk, Eli Lilly, Wegovy, Mounjaro, weightlosss
Novo Nordisk shrugs off supply issues with record sales
Pharmaphorum
Thu, 11/2/23 - 11:37 am
Tags:
Novo Nordisk, Ozempic, earnings
Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis
Stat
Thu, 11/2/23 - 11:35 am
Tags:
Novo Nordisk, Wegovy, osteoarthritis
Pfizer’s twice daily pill for obesity hopes to rival Wegovy and Mounjaro
Stat
Thu, 10/26/23 - 11:24 am
Tags:
Pfizer, danuglipron, obesity, Wegovy, Mounjaro, Novo Nordisk
Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.
Motley Fool
Wed, 10/25/23 - 09:51 am
Tags:
Novo Nordisk, Ozempic, Wegovy, diabetes, weight loss
Belgium plans temporary ban on use of Ozempic for weight loss
Yahoo/Reuters
Tue, 10/24/23 - 09:39 am
Tags:
Novo Nordisk, Ozempic, diabetes, weight loss, Belgium, drug shortages
NASH on the Cusp: An Emerging Market Opportunity
BioSpace
Mon, 10/23/23 - 09:53 am
Tags:
NASH, Viking Therapeutics, Madrigal Pharmaceuticals, Terns Pharmaceuticals, Akero Therapeutics, Hepion Pharmaceuticals, Novo Nordisk, Galmed Pharmaceuticals
GE HealthCare, Novo Nordisk partner to treat diabetes and obesity with ultrasound
Mass Device
Fri, 10/20/23 - 10:14 am
Tags:
Medtech, GE Healthcare, Novo Nordisk, PFUS, ultrasound, obesity, type 2 diabetes
Novo Nordisk, with coffers filling with cash, buys rival to Bayer's kidney drug Kerendia in $1.3B deal
Fierce Biotech
Mon, 10/16/23 - 10:24 am
Tags:
Novo Nordisk, KBP Biosciences, Bayer, chronic kidney disease, Kerendia, ocedurenone, hypertension
High-flying Novo Nordisk once again dials up its 2023 sales and profit expectations
Fierce Pharma
Fri, 10/13/23 - 12:04 pm
Tags:
Novo Nordisk, Ozempic, Wegovy
Fresenius Medical: effect of drugs like Ozempic on patient numbers is neutral
Yahoo/Reuters
Thu, 10/12/23 - 05:24 pm
Tags:
Fresenius Medical Care, Ozempic, diabetes, weight loss, Novo Nordisk, dialysis, Medtech
Far More Employers Could Cover Weight Loss Drugs Like Wegovy Next Year—Here’s What That Means For Costs
Forbes
Thu, 10/12/23 - 11:40 am
Tags:
weight loss, Ozempic, Wegovy, Novo Nordisk, Eli Lilly, Mounjaro
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
CP Wire/Businesswire
Wed, 10/11/23 - 11:50 pm
Tags:
weight loss, patients, physicians, Sermo, Novo Nordisk, Eli Lilly, Ozempic, Wegovy, Mounjaro
Wed, 10/11/23 - 03:40 pm
Tags:
weight loss, patients, physicians, Sermo, Novo Nordisk, Eli Lilly, Ozempic, Wegovy, Mounjaro
Novo Ends Semaglutide Kidney Study Early Due to Strong Efficacy Signals
BioSpace
Wed, 10/11/23 - 10:15 am
Tags:
Novo Nordisk, semaglutide, clinical trials, diabetes, chronic kidney disease
2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not
Motley Fool
Fri, 10/6/23 - 10:08 am
Tags:
Novo Nordisk, Eli Lilly, Ozempic, Mounjaro, diabetes, weight loss
Here's the Best Big Pharma Stock of the Decade so Far (and It's Not Even Close)
Motley Fool
Fri, 10/6/23 - 10:05 am
Tags:
Eli Lilly, Regeneron, Novo Nordisk
GLP-1 Agonists, Like Ozempic and Wegovy, Have Risk of Gut Issues: Study
BioSpace
Thu, 10/5/23 - 09:07 pm
Tags:
Novo Nordisk, Ozempic, Wegovy, GLP-1 agonist, JAMA
At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide
Fierce Pharma
Thu, 10/5/23 - 10:21 am
Tags:
Viatris, generics, Novo Nordisk, Ozempic, Wegovy, diabetes, patents, USPTO
US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic
Yahoo/Reuters
Tue, 10/3/23 - 07:35 pm
Tags:
patents, Novo Nordisk, generics, Wegovy, Ozempic

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.